A double blind investigation of piracetam (Nootropil) vs placebo in geriatric memory. – Cost Effective Supplements

A double blind investigation of piracetam (Nootropil) vs placebo in geriatric memory.

Quick navigation

Link
Conclusion
Supplements
Functions
Systems

Link to full study

http://www.ncbi.nlm.nih.gov/pubmed/360232

Conclusion of this study

Fifty Patients completed the investigation (25 piracetam, 25 placebo). There were no significant statistical differences between the two groups of patients on all measures utilized except for the Clinical Global Evaluation, where 52% of the patients on piracetam showed minimal improvement versus 25% of the placebo group (P less than 0.05).